首页> 外文期刊>Npj - Primary Care Respiratory Medicine >Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study
【24h】

Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study

机译:非小细胞肺癌的诊断途径:描述性队列研究

获取原文
           

摘要

Little has been published on the diagnostic and referral pathway for lung cancer in Australia. This study set out to quantify general practitioner (GP) and lung specialist attendance and diagnostic imaging in the lead-up to a diagnosis of non-small cell lung cancer (NSCLC) and identify common pathways to diagnosis in New South Wales (NSW), Australia. We used linked health data for participants of the 45 and Up Study (a NSW population-based cohort study) diagnosed with NSCLC between 2006 and 2012. Our main outcome measures were GP and specialist attendances, X-rays and computed tomography (CT) scans of the chest and lung cancer-related hospital admissions. Among our study cohort ( N ?=?894), 60% ( n ?=?536) had ≥4 GP attendances in the 3 months prior to diagnosis of NSCLC, 56% ( n ?=?505) had GP-ordered imaging (chest X-ray or CT scan), 39% ( N ?=?349) attended a respiratory physician and 11% ( N ?=?102) attended a cardiothoracic surgeon. The two most common pathways to diagnosis, accounting for one in three people, included GP and lung specialist (respiratory physician or cardiothoracic surgeon) involvement. Overall, 25% of people ( n ?=?223) had an emergency hospital admission. For 14% of people ( N ?=?129), an emergency hospital admission was the only event identified on the pathway to diagnosis. We found little effect of remoteness of residence on access to services. This study identified a substantial proportion of people with NSCLC being diagnosed in an emergency setting. Further research is needed to establish whether there were barriers to the timely diagnosis of these cases. Lung cancer: The pathways to diagnosis Examining events leading to the diagnosis of non-small cell lung cancer (NSCLC) in Australia yields insights to guide further research and perhaps improve the pathways to diagnosis. NSCLC is by far the most common form of lung cancer. Researchers, led by the Cancer Institute New South Wales, investigated clinical care contacts leading to diagnosis, using a descriptive cohort study of 894 patients diagnosed between 2006 and 2012. The researchers quantified contact with GPs and lung specialists, hospital admissions and diagnostic imaging procedures. Living in remote locations had little influence on access to services. More than half of the patients did not see a lung specialist during the pathway to diagnosis, while a quarter received their diagnosis in an emergency setting. Further research should investigate whether there are barriers preventing timely diagnosis.
机译:在澳大利亚,关于肺癌的诊断和转诊途径的文献很少。这项研究旨在对非小细胞肺癌(NSCLC)诊断之前的全科医生(GP)和肺科专家就诊和诊断成像进行量化,并确定新南威尔士州(NSW)的常见诊断途径,澳大利亚。我们使用链接的健康数据作为2006年至2012年之间诊断为NSCLC的45岁及以上研究(一项基于新南威尔士州人群的队列研究)的参与者。我们的主要结局指标是全科医生和专科医生出诊,X光检查和计算机断层扫描(CT)扫描与胸部和肺癌相关的医院入院。在我们的研究队列(N = 894)中,有60%(n = 536)在NSCLC诊断前3个月内有≥4名GP出勤,56%(n = 505)有GP顺序成像(胸部X射线或CT扫描),有39%(N == 349)曾就诊于呼吸内科医师,有11%(N == 102)曾就诊于心胸外科医师。两种最常见的诊断途径(占三分之一)包括GP和肺专科医生(呼吸内科或心胸外科医生)的参与。总体而言,有25%的人(n = 223)接受了急诊入院。对于14%的人(N = 129),在诊断路径上唯一确定的事件是急诊入院。我们发现居住地点偏远对获得服务的影响很小。这项研究确定了在紧急情况下被诊断出患有NSCLC的人的比例很高。需要进一步的研究来确定是否存在及时诊断这些病例的障碍。肺癌:诊断途径在澳大利亚,导致非小细胞肺癌(NSCLC)诊断的检查事件产生了深刻的见识,可为进一步研究提供指导,并可能改善诊断途径。迄今为止,NSCLC是肺癌的最常见形式。由新南威尔士州癌症研究所领导的研究人员,通过描述性队列研究,对2006年至2012年之间诊断出的894名患者进行了调查,调查了导致诊断的临床护理联系方式。研究人员对与全科医生和肺部专家的联系,住院情况和诊断成像程序进行了量化。住在偏远地区对获得服务的影响很小。超过一半的患者在诊断过程中未见过肺科专家,而四分之一的患者在紧急情况下接受了诊断。进一步的研究应调查是否存在妨碍及时诊断的障碍。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号